Parallel Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.7K | Buy |
9
+4
| +80% | +$699 | ﹤0.01% | 3425 |
|
|
2025
Q4 | $850 | Buy |
5
+3
| +150% | +$460 | ﹤0.01% | 3325 |
|
|
2025
Q3 | $264 | Hold |
2
| – | – | ﹤0.01% | 3412 |
|
|
2025
Q2 | $264 | Sell |
2
-256
| -99% | -$27.8K | ﹤0.01% | 3390 |
|
|
2025
Q1 | $32K | Buy |
258
+119
| +86% | +$15.5K | ﹤0.01% | 1892 |
|
|
2024
Q4 | $17.1K | Buy |
139
+63
| +83% | +$7.42K | ﹤0.01% | 2212 |
|
|
2024
Q3 | $8.47K | Buy |
76
+9
| +13% | +$986 | ﹤0.01% | 2455 |
|
|
2024
Q2 | $7.15K | Buy |
67
+28
| +72% | +$3.08K | ﹤0.01% | 2431 |
|
|
2024
Q1 | $4.7K | Sell |
39
-49
| -56% | -$6K | ﹤0.01% | 2547 |
|
|
2023
Q4 | $10.8K | Sell |
88
-47
| -35% | -$5.87K | ﹤0.01% | 2257 |
|
|
2023
Q3 | $17.5K | Buy |
135
+95
| +238% | +$12.7K | ﹤0.01% | 1913 |
|
|
2023
Q2 | $4.96K | Sell |
40
-29
| -42% | -$3.9K | ﹤0.01% | 2433 |
|
|
2023
Q1 | $10.1K | Buy |
69
+37
| +116% | +$5.47K | ﹤0.01% | 2121 |
|
|
2022
Q4 | $5.1K | Sell |
32
-13
| -29% | -$1.91K | ﹤0.01% | 2323 |
|
|
2022
Q3 | $6K | Sell |
45
-9
| -17% | -$1.37K | ﹤0.01% | 2215 |
|
|
2022
Q2 | $8K | Sell |
54
-8
| -13% | -$1.23K | ﹤0.01% | 2084 |
|
|
2022
Q1 | $10K | Sell |
62
-46
| -43% | -$6.67K | ﹤0.01% | 2027 |
|
|
2021
Q4 | $14K | Buy |
108
+49
| +83% | +$6.44K | ﹤0.01% | 1964 |
|
|
2021
Q3 | $8K | Sell |
59
-79
| -57% | -$11.9K | ﹤0.01% | 2180 |
|
|
2021
Q2 | $25K | Buy |
138
+12
| +10% | +$2.08K | ﹤0.01% | 1557 |
|
|
2021
Q1 | $21K | Buy |
126
+27
| +27% | +$4.44K | ﹤0.01% | 1561 |
|
|
2020
Q4 | $16K | Sell |
99
-46
| -32% | -$6.85K | ﹤0.01% | 1586 |
|
|
2020
Q3 | $21K | Sell |
145
-42
| -22% | -$5.21K | ﹤0.01% | 1421 |
|
|
2020
Q2 | $20K | Buy |
187
+87
| +87% | +$9.62K | ﹤0.01% | 1417 |
|
|
2020
Q1 | $9K | Buy |
100
+30
| +43% | +$3.88K | ﹤0.01% | 1655 |
|
|
2019
Q4 | $10K | Buy |
70
+47
| +204% | +$6.4K | ﹤0.01% | 1720 |
|
|
2019
Q3 | $3K | Hold |
23
| – | – | ﹤0.01% | 2063 |
|
|
2019
Q2 | $3K | Hold |
23
| – | – | ﹤0.01% | 1990 |
|
|
2019
Q1 | $3K | Hold |
23
| – | – | ﹤0.01% | 1980 |
|
|
2018
Q4 | $2K | Sell |
23
-12
| -34% | -$1.78K | ﹤0.01% | 1878 |
|
|
2018
Q3 | $6K | Hold |
35
| – | – | ﹤0.01% | 1656 |
|
|
2018
Q2 | $6K | Hold |
35
| – | – | ﹤0.01% | 1535 |
|
|
2018
Q1 | $5K | Hold |
35
| – | – | ﹤0.01% | 1558 |
|
|
2017
Q4 | $5K | Hold |
35
| – | – | ﹤0.01% | 1574 |
|
|
2017
Q3 | $5K | Hold |
35
| – | – | ﹤0.01% | 1586 |
|
|
2017
Q2 | $5K | Buy |
+35
| New | +$5.35K | ﹤0.01% | 1594 |
|
Other funds holding JAZZ
VPM
VCM
EC
Parallel Advisors's JAZZ Position: Q1 2026 in Review
Parallel Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 80% in Q1 2026, buying an estimated $699 and bringing the position to 9 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3425.
Parallel Advisors first reported a position in JAZZ in Q2 2017 and has held it in 36 quarters since. The position peaked at $32K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Parallel Advisors held 9 shares of Jazz Pharmaceuticals worth $1.7K as of Q1 2026.
- Parallel Advisors bought 4 Jazz Pharmaceuticals shares in Q1 2026, an estimated $699.
- Jazz Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3425 holding.
- Parallel Advisors first reported a position in Jazz Pharmaceuticals in Q2 2017 and has held it in 36 quarters since.
- Parallel Advisors's Jazz Pharmaceuticals position peaked at $32K in Q1 2025.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.